Abstract Human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) has been the most challenging subtype of BC. consisting of 20% of BC with an apparent correlation with poor prognosis. Despite that pyrotinib. a new HER2 inhibitor. https://toyscyclers.shop/product-category/cribs/